GST : 27AEUPJ3828B1ZE

Call us now

08045475302

Send Inquiry

Request To Call Back

Canmab 440 ( Trastuzumab ) Injection

Name: Canmab 440 ( Trastuzumab ) Injection
Brand: DATTATRAYA MEDICAL & GENERAL STORES
Price: 64690.72 INR
Availability: InStock

Price 64690.72 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Canmab 440 ( Trastuzumab ) Injection Specification

Origin of Medicine
India

Brand Name
CANMAB

Packaging Type
Vial

Pacakaging (Quantity Per Box)
1 vial

Salt Composition
Trastuzumab

Dosage Form
Injection

Indication
Breast and gastric cancer

Life Span
36 months

Drug Type
Biological

Ingredients
Trastuzumab

Physical Form
Lyophilized Powder

Function
Anti-Cancer

Recommended For
HER2-positive breast cancer

Dosage
As directed by the physician

Dosage Guidelines
Administer under medical supervision

Suitable For
Adults

Quantity
1 vial per box

Storage Instructions
Store between 2C and 8C

Colour
White to off-white

Prescription
Required

Route
Intravenous

Strength
440 mg

Reconstitution
With bacteriostatic water

Patient Type
Adult female

HER2
Targeted therapy

Molecular Type
Monoclonal antibody

Vial Size
20 ml

Single Use
Yes

Box Contents
1 vial, 1 solvent

Canmab 440 ( Trastuzumab ) Injection Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About Canmab 440 ( Trastuzumab ) Injection

Experience the elite standard in HER2-positive breast cancer therapy with Canmab 440 (Trastuzumab) Injection. Now available at an exceptional markdown, this lavish anti-cancer solution delivers powerful, targeted treatment with a sensational price cut. Each 20 ml vial contains 440 mg of lyophilized Trastuzumab, designed for adult females and suitable for intravenous use after reconstitution. The box combines both convenience and safety: 1 vial and 1 solvent, for single-use only. Canmab's advanced monoclonal antibody formulation ensures precision targeting, making it the distinguished choice for those seeking high efficacy at a discounted rate.

Versatile Application & Exceptional Features

Canmab 440 (Trastuzumab) Injection is tailored for HER2-positive breast and gastric cancer, delivering targeted therapy directly where it counts. Designed for hospital oncology wards and specialized treatment centers, this formulation stands out with its single-use vial, precise dosage, and advanced molecular structure. Its white to off-white lyophilized powder ensures optimal stability, while ease of reconstitution provides consistent results under medical supervision, making it a sensation in elite cancer treatment protocols.

Delivery Timeline & Export Excellence

Estimate swift worldwide delivery for Canmab 440, expertly packaged in robust 20 ml vials with secured solvent, reflecting premium market value. Each export order undergoes rigorous quality checks, ensuring every sale price equates to superior safety and consistent efficacy. Main markets include Asia, Africa, and the Middle East, supported by a dedicated exporter network in India that guarantees prompt and reliable shipment, maximizing value for international healthcare providers.

FAQ's of Canmab 440 ( Trastuzumab ) Injection:

Q: How should Canmab 440 (Trastuzumab) Injection be administered?

A: Canmab 440 must be reconstituted with bacteriostatic water and administered intravenously, exclusively under the supervision of a healthcare professional following the physician's dosage guidelines.

Q: What conditions is Canmab 440 recommended for?

A: This injection is specifically designed for the treatment of HER2-positive breast cancer and gastric cancer in adult female patients, offering targeted therapy to improve clinical outcomes.

Q: When should Canmab 440 be used during treatment?

A: Canmab 440 is intended for use during specific phases of targeted cancer therapy, as directed by your oncologist. The dosage and timing depend on individual patient needs and medical advice.

Q: Where can I store Canmab 440 to maintain its potency?

A: To preserve its effectiveness, store Canmab 440 between 2C and 8C until reconstitution and use. Avoid freezing or exposing the vial to direct sunlight.

Q: What are the special features of Canmab 440 (Trastuzumab) Injection?

A: Canmab 440 boasts elite features including a single-use vial, precise dosage form, robust packaging, and a life span of 36 months. Its monoclonal antibody composition ensures selective action against HER2-positive cancer cells.

Q: What benefits can patients expect from Canmab 440 therapy?

A: Patients may benefit from improved disease control, enhanced survival prospects, and reduced risk of cancer progression. The targeted action of Trastuzumab makes this product a trusted addition to modern cancer treatment protocols.

Tell us about your requirement